BE790440A
(pt)
|
1971-10-23 |
1973-04-24 |
Bayer Ag |
|
JPS50106981U
(pt)
|
1974-02-08 |
1975-09-02 |
|
|
US3906953A
(en)
|
1974-05-23 |
1975-09-23 |
American Optical Corp |
Endoscopic surgical laser system
|
SU509578A1
(ru)
|
1974-09-19 |
1976-04-05 |
Стерлитамакский Химический Завод |
Способ получени пропилендиаминов
|
GB1502312A
(en)
|
1975-03-20 |
1978-03-01 |
Ici Ltd |
Quinolone derivatives
|
IE43079B1
(en)
|
1975-03-20 |
1980-12-17 |
Ici Ltd |
Quinolone derivatives
|
FR2311776A1
(fr)
|
1975-05-23 |
1976-12-17 |
Sogeras |
Diamino-2,4 bromo-5 chloro-6 pyrimidines et procede pour leur preparation
|
GB1570494A
(en)
|
1975-11-28 |
1980-07-02 |
Ici Ltd |
Thienopyrimidine derivatives and their use as pesticides
|
JPS5382783U
(pt)
|
1976-12-13 |
1978-07-08 |
|
|
JPS5752334Y2
(pt)
|
1977-03-16 |
1982-11-13 |
|
|
US4196207A
(en)
|
1977-05-23 |
1980-04-01 |
Ici Australia Limited |
Process for controlling eradicating or preventing infestations of animals by Ixodid ticks
|
DE2750288A1
(de)
|
1977-11-10 |
1979-05-17 |
Thomae Gmbh Dr K |
Neue 9-(omega-heteroarylamino- alkylamino)-erythromycine, ihre salze, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
|
US4432979A
(en)
|
1981-10-26 |
1984-02-21 |
William H. Rorer, Inc. |
Pyridone compounds
|
FI824314L
(fi)
|
1981-12-16 |
1983-06-17 |
Sankyo Co |
Thienopyrimidin-derivater, deras framstaellning och deras medicinska anvaendning
|
US4358453A
(en)
|
1982-01-08 |
1982-11-09 |
Schering Corporation |
1,2,4-Triazolo[4,3-a]pyridines
|
US4520025A
(en)
|
1982-07-21 |
1985-05-28 |
William H. Rorer, Inc. |
Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses
|
DE3406329A1
(de)
|
1984-02-22 |
1985-08-22 |
Merck Patent Gmbh, 6100 Darmstadt |
Pyridone
|
US4550166A
(en)
|
1984-05-21 |
1985-10-29 |
American Cyanamid Company |
(Pyridinyl)-1,2,4-triazolo[4,3-a]pyridines
|
US5175157A
(en)
|
1985-11-27 |
1992-12-29 |
Boehringer Ingelheim Gmbh |
Cyclic amine derivatives, pharmaceutical compositions containing these compounds and methods for preparing them
|
US4866074A
(en)
|
1987-05-08 |
1989-09-12 |
Rorer Pharmaceutical Corporation |
Naphtheridinone- and pyridooxazinone-pyridone compounds, cardiotonic compositions including same, and their uses
|
EP0308020A3
(en)
|
1987-09-18 |
1990-12-05 |
Merck & Co. Inc. |
5-(aryl and heteroaryl)-6-(aryl and heteroaryl)-1,2-dihydro-2-oxo 3-pyridinecarboxylic acids and derivatives thereof
|
US5260293A
(en)
|
1988-01-30 |
1993-11-09 |
Merck Sharp & Dohme Limited |
Pyrazines, pyrimidines and pyridazines useful in the treatment of senile dementia
|
GB8804448D0
(en)
|
1988-02-25 |
1988-03-23 |
Smithkline Beckman Intercredit |
Compounds
|
JP2614081B2
(ja)
|
1988-05-27 |
1997-05-28 |
大塚化学株式会社 |
光学活性β−ラクタム誘導体の製造法
|
EP0365486B1
(en)
|
1988-10-20 |
1995-07-19 |
Sandoz Ag |
Fibre-reactive azo dyes
|
US5164506A
(en)
|
1988-12-14 |
1992-11-17 |
Bayer Aktiengesellschaft |
Substituted 2-pyridones and pyrid-2-thiones compounds
|
US5032602A
(en)
|
1988-12-14 |
1991-07-16 |
Bayer Aktiengesellschaft |
Inhibiting HMG-CoA reductase with novel substituted 2-pyridones and pyrid-2-thiones
|
HU206337B
(en)
|
1988-12-29 |
1992-10-28 |
Mitsui Petrochemical Ind |
Process for producing pyrimidine derivatives and pharmaceutical compositions
|
US5236917A
(en)
|
1989-05-04 |
1993-08-17 |
Sterling Winthrop Inc. |
Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
|
US5280026A
(en)
|
1989-05-30 |
1994-01-18 |
Smithkline Beecham Intercredit B.V. |
Thienopyrimidines
|
AU622330B2
(en)
|
1989-06-23 |
1992-04-02 |
Takeda Chemical Industries Ltd. |
Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
|
US4978663A
(en)
|
1989-08-16 |
1990-12-18 |
Hoechst-Roussel Pharmaceuticals Inc. |
5-(1-aminocyclohexyl)-2(1H)-pyridinone compounds which have pharmaceutical utility
|
GB8926560D0
(en)
|
1989-11-24 |
1990-01-17 |
Zambeletti Spa L |
Pharmaceuticals
|
IL96432A0
(en)
|
1989-11-30 |
1991-08-16 |
Schering Ag |
Pesticidal compositions containing pyridine derivatives and novel pyridine derivatives
|
DE3940480A1
(de)
|
1989-12-07 |
1991-06-13 |
Bayer Ag |
Chromogene enaminverbindungen, ihre herstellung und verwendung als farbbildner
|
AU6979091A
(en)
|
1989-12-22 |
1991-07-24 |
Upjohn Company, The |
Pyridinones useful as antiatherosclerotic agents
|
FR2657610A1
(fr)
|
1990-01-29 |
1991-08-02 |
Rhone Poulenc Agrochimie |
Triazolopyridines herbicides.
|
GB9104238D0
(en)
|
1990-03-16 |
1991-04-17 |
Ici Pharma |
3-tetrazolylthiomethyl cephalosporin antibiotics
|
DE4008726A1
(de)
|
1990-03-19 |
1991-09-26 |
Basf Ag |
Thieno(2,3-d)pyrimidinderivate
|
CA2039411A1
(en)
|
1990-03-30 |
1991-10-01 |
Ronnie Gerald Edie |
Thienopyrimidine derivatives
|
ATE180475T1
(de)
|
1990-09-21 |
1999-06-15 |
Rohm & Haas |
Dihydropyridazinone und pyridazinone als fungizide
|
KR920008026A
(ko)
|
1990-10-24 |
1992-05-27 |
오노 화아마슈티칼 캄파니 리미팃드 |
이소퀴놀리논 유도체 또는 이의 무독성 산부가염 또는 이의 수화물, 이의 제조방법 및 이를 포함하는 약제 조성물
|
WO1992018115A1
(en)
|
1991-04-18 |
1992-10-29 |
Dr Lo Zambeletti S.P.A. |
Use of heterocyclic compounds for the treatment of inflammatory pain
|
DE4122240A1
(de)
|
1991-07-05 |
1993-01-07 |
Boehringer Mannheim Gmbh |
Dibenz(b,e)azepinderivate und diese enthaltende arzneimittel
|
US5332750A
(en)
|
1991-09-04 |
1994-07-26 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
1,2-dihydro-2-oxopyridines
|
DE4129340A1
(de)
|
1991-09-04 |
1993-03-11 |
Merck Patent Gmbh |
1,2-dihydro-2-oxopyridine
|
DE4131924A1
(de)
|
1991-09-25 |
1993-07-08 |
Hoechst Ag |
Substituierte 4-alkoxypyrimidine, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel
|
US5204198A
(en)
|
1991-10-28 |
1993-04-20 |
Eastman Kodak Company |
Photoelectrographic elements utilizing nonionic sulfonic acid photogenerators
|
US5416099A
(en)
|
1991-10-29 |
1995-05-16 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
DE4221583A1
(de)
|
1991-11-12 |
1993-05-13 |
Bayer Ag |
Substituierte biphenylpyridone
|
JP2878531B2
(ja)
|
1991-12-16 |
1999-04-05 |
富士写真フイルム株式会社 |
ハロゲン化銀写真感光材料
|
US5378720A
(en)
|
1991-12-19 |
1995-01-03 |
Sterling Winthrop Inc. |
Saccharin derivative proteolytic enzyme inhibitors
|
AU668694B2
(en)
|
1991-12-19 |
1996-05-16 |
Sanofi-Synthelabo |
Saccharin derivative proteolytic enzyme inhibitors
|
TW219935B
(pt)
|
1991-12-25 |
1994-02-01 |
Mitsubishi Chemicals Co Ltd |
|
GB9200293D0
(en)
|
1992-01-08 |
1992-02-26 |
Wyeth John & Brother Ltd |
Piperazine derivatives
|
GB9201694D0
(en)
|
1992-01-27 |
1992-03-11 |
Smithkline Beecham Intercredit |
Compounds
|
JP3042156B2
(ja)
|
1992-02-20 |
2000-05-15 |
田辺製薬株式会社 |
ナフタレン誘導体、その製法及びその合成中間体
|
DE4206045A1
(de)
|
1992-02-27 |
1993-09-02 |
Bayer Ag |
Sulfonylbenzyl substituierte pyridone
|
US5922773A
(en)
|
1992-12-04 |
1999-07-13 |
The Children's Medical Center Corp. |
Glaucoma treatment
|
AU660132B2
(en)
|
1992-12-21 |
1995-06-08 |
Bayer Aktiengesellschaft |
Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridine
|
SE9300657D0
(sv)
|
1993-02-26 |
1993-02-26 |
Astra Ab |
New compounds
|
US5814645A
(en)
|
1993-03-24 |
1998-09-29 |
Bayer Aktiengesellschaft |
Arylor hetaryl substituted nitrogen heterocycles and their use as pesticides
|
DE4316077A1
(de)
|
1993-05-13 |
1994-11-17 |
Bayer Ag |
Substituierte Mono- und Bihydridylmethylpyridone
|
JPH08511538A
(ja)
|
1993-06-09 |
1996-12-03 |
スミスクライン・ビーチャム・コーポレイション |
二環式フィブリノゲン拮抗物質
|
DE4326758A1
(de)
|
1993-08-10 |
1995-02-16 |
Basf Ag |
[1,3,4]Triazolo[1,5-a]pyridine
|
BR9407313A
(pt)
|
1993-08-19 |
1996-10-08 |
Janssen Pharmaceutica Nv |
Ariloxialquil diaminas substituÍdas vasoconstritivas
|
NZ271995A
(en)
|
1993-08-19 |
1996-11-26 |
Janssen Pharmaceutica Nv |
2-(aminoalkyl)dihydrobenzopyran derivatives; medicaments; and intermediate compounds
|
AU7467294A
(en)
|
1993-08-20 |
1995-03-21 |
Banyu Pharmaceutical Co., Ltd. |
Tyrosine kinase inhibitor
|
US5424435A
(en)
|
1993-10-18 |
1995-06-13 |
Olin Corporation |
1-hydroxy-6-substituted-2-pyridones
|
US5500420A
(en)
|
1993-12-20 |
1996-03-19 |
Cornell Research Foundation, Inc. |
Metabotropic glutamate receptor agonists in the treatment of cerebral ischemia
|
US5679683A
(en)
|
1994-01-25 |
1997-10-21 |
Warner-Lambert Company |
Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
|
RU2155188C2
(ru)
|
1994-03-10 |
2000-08-27 |
Фудзисава Фармасьютикал Со., Лтд. |
Производные нафталина, фармацевтическая композиция
|
ES2079323B1
(es)
|
1994-06-21 |
1996-10-16 |
Vita Invest Sa |
Derivados de indol utiles para el tratamiento de la migraña, composicion y uso correspondientes.
|
GB9416554D0
(en)
|
1994-08-19 |
1994-10-12 |
Ciba Geigy Ag |
Glutamate receptor
|
AU3325295A
(en)
|
1994-08-24 |
1996-03-14 |
Eli Lilly And Company |
Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor antagonists
|
US6017697A
(en)
|
1994-11-14 |
2000-01-25 |
Eli Lilly And Company |
Excitatory amino acid receptor protein and related nucleic acid compounds
|
US5473077A
(en)
|
1994-11-14 |
1995-12-05 |
Eli Lilly And Company |
Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor agonists
|
US5512576A
(en)
|
1994-12-02 |
1996-04-30 |
Sterling Winthrop Inc. |
2-substituted 1,2,5,-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
|
US5789426A
(en)
|
1995-01-20 |
1998-08-04 |
Cornell Research Foundation, Inc. |
Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation
|
US5869486A
(en)
|
1995-02-24 |
1999-02-09 |
Ono Pharmaceutical Co., Ltd. |
Fused pyrimidines and pyriazines as pharmaceutical compounds
|
DE19507522C2
(de)
|
1995-03-03 |
2003-05-28 |
Basf Ag |
Verfahren zur Herstellung von 3,4-Dihydroisochinolinverbindungen und 3,4-Dihydroisochinolinium-Salzen
|
TW324008B
(en)
|
1995-03-13 |
1998-01-01 |
Ishihara Sangyo Kaisha |
Pyridone sulfonylurea compound, its production process and weed killer containing such compound
|
DE19510965A1
(de)
|
1995-03-24 |
1996-09-26 |
Asta Medica Ag |
Neue Pyrido/3,2-e/pyrazinone mit antiasthmatischer Wirksamkeit und Verfahren zu deren Herstellung
|
EP0826671B1
(en)
|
1995-04-27 |
2004-12-29 |
Mitsubishi Pharma Corporation |
Heterocyclic amide compounds and medicinal use of the same
|
JPH08325248A
(ja)
|
1995-05-26 |
1996-12-10 |
Chugoku Kayaku Kk |
テトラゾール類の新規な合成試薬及びそれを用いたテトラゾール類の製造方法
|
US5849587A
(en)
|
1995-06-09 |
1998-12-15 |
Cornell Research Foundation, Inc. |
Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells
|
US5659033A
(en)
|
1995-09-13 |
1997-08-19 |
Neurogen Corporation |
N-aminoalkylfluorenecarboxamides; a new class of dopamine receptor subtype specific ligands
|
EP0850235B1
(fr)
|
1995-09-15 |
1999-12-01 |
Sanofi-Synthelabo |
Derives de quinolein-2(1h)-one comme antagonistes de la serotonine
|
US6130217A
(en)
|
1995-09-20 |
2000-10-10 |
Pfizer Inc |
Compounds enhancing antitumor activity of other cytotoxic agents
|
JPH1045750A
(ja)
|
1995-09-20 |
1998-02-17 |
Takeda Chem Ind Ltd |
アゾール化合物、その製造方法及び用途
|
AR004010A1
(es)
|
1995-10-11 |
1998-09-30 |
Glaxo Group Ltd |
Compuestos heterociclicos
|
EA000710B1
(ru)
|
1995-12-08 |
2000-02-28 |
Жансен Фармасетика Н.В. |
(имидазол-5-ил)метил-2-хинолиноновые производные, ингибирующие фарнезилпротеин-трансферазу
|
JP2000504336A
(ja)
|
1996-02-02 |
2000-04-11 |
ゼネカ・リミテッド |
薬学製剤として有用なヘテロ環式化合物
|
GB9602166D0
(en)
|
1996-02-02 |
1996-04-03 |
Zeneca Ltd |
Aminoheterocyclic derivatives
|
GB9602294D0
(en)
|
1996-02-05 |
1996-04-03 |
Zeneca Ltd |
Heterocyclic compounds
|
US6084084A
(en)
|
1996-02-21 |
2000-07-04 |
Nps Pharmaceuticals, Inc. |
Human metabotropic glutamate receptor
|
US5710274A
(en)
|
1996-02-28 |
1998-01-20 |
Neurogen Corporation |
N-aminoalkyldibenzofurancarboxamides; new dopamine receptor subtype specific ligands
|
US5756518A
(en)
|
1996-04-02 |
1998-05-26 |
Kowa Co., Ltd. |
Phenylene derivatives
|
JPH1029979A
(ja)
|
1996-04-12 |
1998-02-03 |
Ajinomoto Co Inc |
新規ピリジン誘導体
|
WO1997046532A1
(en)
|
1996-06-03 |
1997-12-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
2-benzyl-4-sulfonyl-4h-isoquinolin-1,3-diones and their use as anti-inflammatory agents
|
WO1998006724A1
(fr)
|
1996-08-09 |
1998-02-19 |
Yamanouchi Pharmaceutical Co., Ltd. |
Agonistes du recepteur du glutamate metabotropique
|
DE19632423A1
(de)
|
1996-08-12 |
1998-02-19 |
Merck Patent Gmbh |
Thienopyrimidine
|
IL128428A0
(en)
|
1996-08-14 |
2000-01-31 |
Zeneca Ltd |
Substituted pyrimidine derivatives and their pharmaceutical use
|
DE69710594T2
(de)
|
1996-09-16 |
2002-08-29 |
Du Pont Pharm Co |
Eine resorbierbare röntgenopake markierung enthaltendes chirurgisches implantat und verfahren zum verriegeln desselben in einem körper
|
DE19638486A1
(de)
|
1996-09-20 |
1998-03-26 |
Basf Ag |
Hetaroylderivate
|
DE19638484A1
(de)
|
1996-09-20 |
1998-03-26 |
Basf Ag |
Hetaroylderivate
|
DE19644228A1
(de)
|
1996-10-24 |
1998-04-30 |
Merck Patent Gmbh |
Thienopyrimidine
|
US6284794B1
(en)
|
1996-11-05 |
2001-09-04 |
Head Explorer Aps |
Method for treating tension-type headache with inhibitors of nitric oxide and nitric oxide synthase
|
WO1998024780A2
(en)
|
1996-12-05 |
1998-06-11 |
Amgen Inc. |
Substituted pyrimidinone and pyridinone compounds and their use
|
DE69812934T2
(de)
|
1997-01-24 |
2004-01-29 |
Conpharma As Oslo |
Gemcitabin-derivate
|
US5855654A
(en)
|
1997-01-30 |
1999-01-05 |
Rohm And Haas Company |
Pyridazinones as marine antifouling agents
|
FR2759366B1
(fr)
|
1997-02-11 |
1999-04-16 |
Centre Nat Rech Scient |
Composes constituant notamment des effecteurs de recepteurs du systeme nerveux central sensibles aux amino acides neuroexcitateurs, leur preparation et leurs applications biologiques
|
US6262068B1
(en)
|
1997-02-21 |
2001-07-17 |
Bristol-Myers Squibb Company |
Lactam derivatives as antiarrhythmic agents
|
AU6230098A
(en)
|
1997-02-27 |
1998-09-18 |
Tanabe Seiyaku Co., Ltd. |
Isoquinolinone derivatives, process for preparing the same, and their use as phosphodiesterase inhibitors
|
ES2131463B1
(es)
|
1997-04-08 |
2000-03-01 |
Lilly Sa |
Derivados de ciclopropilglicina con propiedades farmaceuticas.
|
GB9708945D0
(en)
|
1997-05-01 |
1997-06-25 |
Merck Sharp & Dohme |
Therapeutic agents
|
DE19728996A1
(de)
|
1997-07-07 |
1999-01-14 |
Basf Ag |
Triazolverbindungen und deren Verwendung
|
AU743899B2
(en)
|
1997-07-18 |
2002-02-07 |
Georgetown University |
Bicyclic metabotropic glutamate receptor ligands
|
DK0891978T3
(da)
|
1997-07-18 |
2002-07-01 |
Hoffmann La Roche |
5H-Thiazol(3,2-a)pyrimidinderivativer
|
HUP0003761A3
(en)
|
1997-07-31 |
2001-04-28 |
Celgene Corp Warren |
Substituted alkanohydroxamic acids and pharmaceutical compositions containing them
|
YU6100A
(sh)
|
1997-08-14 |
2002-10-18 |
F.Hoffmann-La Roche Ag. |
Heterociklični viniletri protiv neuroloških poremećaja
|
US6358975B1
(en)
|
1997-08-15 |
2002-03-19 |
Johns Hopkins University |
Method of using selective parp inhibitors to prevent or treat neurotoxicity
|
WO1999011622A1
(en)
|
1997-09-03 |
1999-03-11 |
Guilford Pharmaceuticals Inc. |
Amino-substituted compounds, methods, and compositions for inhibiting parp activity
|
US6121278A
(en)
|
1997-09-03 |
2000-09-19 |
Guilford Pharmaceuticals, Inc. |
Di-n-heterocyclic compounds, methods, and compositions for inhibiting parp activity
|
US6635642B1
(en)
|
1997-09-03 |
2003-10-21 |
Guilford Pharmaceuticals Inc. |
PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
|
US20020028813A1
(en)
|
1997-09-03 |
2002-03-07 |
Paul F. Jackson |
Thioalkyl compounds, methods, and compositions for inhibiting parp activity
|
US20020022636A1
(en)
|
1997-09-03 |
2002-02-21 |
Jia-He Li |
Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity
|
US6197785B1
(en)
|
1997-09-03 |
2001-03-06 |
Guilford Pharmaceuticals Inc. |
Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
|
AU9740998A
(en)
|
1997-09-08 |
1999-03-29 |
F. Hoffmann-La Roche Ag |
Piperidine derivatives against malaria
|
EP0903343B1
(en)
|
1997-09-19 |
2003-05-28 |
SSP Co., Ltd. |
Alpha-Substituted phenylpropionic acid derivative and medicine containing the same
|
US6162804A
(en)
|
1997-09-26 |
2000-12-19 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
US6465484B1
(en)
|
1997-09-26 |
2002-10-15 |
Merck & Co., Inc. |
Angiogenesis inhibitors
|
JP2001518470A
(ja)
|
1997-09-26 |
2001-10-16 |
メルク エンド カムパニー インコーポレーテッド |
新規な血管形成阻害剤
|
JP2001519345A
(ja)
|
1997-10-02 |
2001-10-23 |
メルク エンド カムパニー インコーポレーテッド |
プレニルタンパク質トランスフェラーゼの阻害剤
|
ES2237850T3
(es)
|
1997-10-14 |
2005-08-01 |
Mitsubishi Pharma Corporation |
Compuestos de piperazina y su uso medicinal.
|
WO1999021992A2
(en)
|
1997-10-23 |
1999-05-06 |
Ganimed Pharmaceuticals Gmbh |
Nucleic acid molecules encoding a glutamate receptor
|
JP4321737B2
(ja)
|
1997-12-17 |
2009-08-26 |
塩野義製薬株式会社 |
新規ピリジン化合物
|
EP1045836B1
(en)
|
1997-12-18 |
2008-03-05 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Pyridones as src family sh2 domain inhibitors
|
US6013672A
(en)
|
1997-12-18 |
2000-01-11 |
Uab Research Foundation |
Agonists of metabotropic glutamate receptors and uses thereof
|
SI1042293T1
(sl)
|
1997-12-19 |
2008-08-31 |
Amgen Inc |
Substituirane piridinske in piridazinske spojine in njihova farmacevtska uporaba
|
FR2772763B1
(fr)
|
1997-12-24 |
2004-01-23 |
Sod Conseils Rech Applic |
Nouveaux analogues tetracycliques de camptothecines, leurs procedes de preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant
|
IT1298155B1
(it)
|
1998-01-19 |
1999-12-20 |
Moreno Paolini |
Composti pirimidin 3-ossido per il trattamento delle patologie muscolo-scheletriche, in particolare per il trattamento della
|
US6664250B2
(en)
|
1998-01-20 |
2003-12-16 |
Bristol-Myers Squibb Co. |
Lactam derivatives as antiarrhythmic agents
|
AU734812B2
(en)
|
1998-01-28 |
2001-06-21 |
Taisho Pharmaceutical Co., Ltd. |
Fluorine-containing amino acid derivatives
|
US6200977B1
(en)
|
1998-02-17 |
2001-03-13 |
Tularik Inc. |
Pyrimidine derivatives
|
KR100372981B1
(ko)
|
1998-03-17 |
2003-02-25 |
화이자 프로덕츠 인크. |
비시클로[2.2.1]헵탄 및 관련 화합물
|
EP1076655A1
(en)
|
1998-04-08 |
2001-02-21 |
Novartis AG |
N-pyridonyl herbicides
|
AU3170099A
(en)
|
1998-04-16 |
1999-11-08 |
Yamanouchi Pharmaceutical Co., Ltd. |
Remedies for obesity
|
EP0955301A3
(en)
|
1998-04-27 |
2001-04-18 |
Pfizer Products Inc. |
7-aza-bicyclo[2.2.1]-heptane derivatives, their preparation and use according to their affinity for neuronal nicotinic acetylcholine receptors
|
DE19822198C2
(de)
|
1998-05-16 |
2003-02-13 |
Wella Ag |
Oxonolfarbstoffe enthaltende Mittel und Verfahren zur Erzeugung von semipermanenten Färbungen auf Haaren
|
JP2002517396A
(ja)
|
1998-06-04 |
2002-06-18 |
アボット・ラボラトリーズ |
細胞接着阻害抗炎症性化合物
|
DE19826671A1
(de)
|
1998-06-16 |
1999-12-23 |
Hoechst Schering Agrevo Gmbh |
1,3-Oxazolin- und 1,3-Thiazolin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel
|
FR2781218B1
(fr)
|
1998-07-15 |
2001-09-07 |
Lafon Labor |
Compositions pharmaceutiques comprenant des 2-quinolones
|
JP2000072751A
(ja)
|
1998-08-26 |
2000-03-07 |
Tanabe Seiyaku Co Ltd |
イソキノリノン誘導体
|
JP2000072731A
(ja)
|
1998-08-31 |
2000-03-07 |
Taisho Pharmaceut Co Ltd |
4−置換−2−アミノビシクロ[3.1.0]ヘキサン−2,6−ジカルボン酸誘導体及び製薬用組成物
|
KR100469182B1
(ko)
|
1998-08-31 |
2005-02-02 |
다이쇼 세이야꾸 가부시끼가이샤 |
6-플루오로비시클로[3.1.0]헥산 유도체
|
EP1109555A4
(en)
|
1998-08-31 |
2001-11-21 |
Merck & Co Inc |
NEW ANGIOGENIC INHIBITORS
|
CH694053A5
(de)
|
1998-09-03 |
2004-06-30 |
Hoffmann La Roche |
Verfahren zur Herstellung von 2-Amino-bicyclo[3.1.0]hexan-2,6-dicarbonsäure-Derivaten.
|
US6284759B1
(en)
|
1998-09-30 |
2001-09-04 |
Neurogen Corporation |
2-piperazinoalkylaminobenzo-azole derivatives: dopamine receptor subtype specific ligands
|
SE9803518D0
(sv)
|
1998-10-15 |
1998-10-15 |
Astra Pharma Prod |
Novel compounds
|
PE20001236A1
(es)
|
1998-11-13 |
2000-11-10 |
Lilly Co Eli |
Moduladores del receptor de aminoacidos excitadores
|
US6133271A
(en)
|
1998-11-19 |
2000-10-17 |
Cell Pathways, Inc. |
Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives
|
US5948911A
(en)
|
1998-11-20 |
1999-09-07 |
Cell Pathways, Inc. |
Method for inhibiting neoplastic cells and related conditions by exposure to thienopyrimidine derivatives
|
EP1006112A1
(en)
|
1998-12-01 |
2000-06-07 |
Cerebrus Pharmaceuticals Limited |
3-Hydroxy-2(1H)-pyridinone or 3-hydroxy-4(1H)-pyridinone derivatives useful as reactive oxygen species (ROS) scavengers
|
DK1133474T3
(da)
|
1998-12-04 |
2007-04-10 |
Bristol Myers Squibb Co |
3-Substituerede 4-arylquinolin-2-onderivater som kaliumkanal-modulatorer
|
US6245759B1
(en)
|
1999-03-11 |
2001-06-12 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
TW564247B
(en)
|
1999-04-08 |
2003-12-01 |
Akzo Nobel Nv |
Bicyclic heteraromatic compound
|
GB9908175D0
(en)
|
1999-04-09 |
1999-06-02 |
Lilly Co Eli |
Method of treating neurological disorders
|
US6723711B2
(en)
|
1999-05-07 |
2004-04-20 |
Texas Biotechnology Corporation |
Propanoic acid derivatives that inhibit the binding of integrins to their receptors
|
US6972296B2
(en)
|
1999-05-07 |
2005-12-06 |
Encysive Pharmaceuticals Inc. |
Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
|
EP1183238A1
(en)
|
1999-05-17 |
2002-03-06 |
Eli Lilly And Company |
Metabotropic glutamate receptor antagonists
|
ATE302194T1
(de)
|
1999-06-02 |
2005-09-15 |
Nps Pharma Inc |
Metabotrope glutamatrezeptorantagonisten zur behandlung von krankheiten des zentralen nervensystems
|
EP1189873A1
(en)
|
1999-06-03 |
2002-03-27 |
Lilly, S.A. |
Excitatory amino acid receptor modulators
|
JP2004509059A
(ja)
|
1999-06-03 |
2004-03-25 |
アボット・ラボラトリーズ |
細胞接着抑制性抗炎症化合物
|
JP4783967B2
(ja)
|
1999-07-21 |
2011-09-28 |
大正製薬株式会社 |
含フッ素アミノ酸誘導体を有効成分とする医薬
|
JP2003506440A
(ja)
|
1999-08-05 |
2003-02-18 |
プレサイエント ニューロファーマ インコーポレイテッド |
中枢神経系に関連する疾患の処置のための1,4−ジアゼピン誘導体
|
US6660753B2
(en)
|
1999-08-19 |
2003-12-09 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
US7040838B2
(en)
|
1999-08-27 |
2006-05-09 |
Kristar Enterprises, Inc. |
High capacity catch basin filtration system with adjustable deflector ring
|
NZ517999A
(en)
|
1999-10-15 |
2004-07-30 |
F |
Benzodiazepine derivatives
|
EP1224175B1
(en)
|
1999-10-15 |
2004-03-17 |
F. Hoffmann-La Roche Ag |
Benzodiazepine derivatives as metabotropic glutamate receptor antagonists
|
ES2234698T3
(es)
|
1999-10-19 |
2005-07-01 |
MERCK & CO., INC. |
Inhibidores de tirosina quinasa.
|
EP1230225A2
(en)
|
1999-11-01 |
2002-08-14 |
Eli Lilly And Company |
Pharmaceutically active 4-substituted pyrimidine derivatives
|
GB2355982A
(en)
|
1999-11-03 |
2001-05-09 |
Lilly Co Eli |
Heterocyclic amino acids
|
AU2220801A
(en)
|
1999-12-22 |
2001-07-03 |
Kyorin Pharmaceutical Co. Ltd. |
Tricyclic compounds and addition salts thereof
|
AU779442B2
(en)
|
2000-01-20 |
2005-01-27 |
Eisai Co. Ltd. |
Novel piperidine compounds and drugs containing the same
|
GB0002100D0
(en)
|
2000-01-28 |
2000-03-22 |
Novartis Ag |
Organic compounds
|
US6800651B2
(en)
|
2000-02-03 |
2004-10-05 |
Eli Lilly And Company |
Potentiators of glutamate receptors
|
PL203805B1
(pl)
|
2000-02-25 |
2009-11-30 |
Hoffmann La Roche |
Zastosowanie cyklicznych związków heteroaromatycznych, lek i cykliczne związki heteroaromatyczne
|
DE10012373A1
(de)
|
2000-03-14 |
2001-09-20 |
Dresden Arzneimittel |
Verwendung von Pyrido[3,2-e]-pyrazinonen als Inhibitoren der Phosphodiesterase 5 zur Therapie von erektiler Dysfunktion
|
GB0007108D0
(en)
|
2000-03-23 |
2000-05-17 |
Novartis Ag |
Organic compounds
|
US6469026B2
(en)
|
2000-03-24 |
2002-10-22 |
Millennium Pharmaceuticals, Inc. |
Isoquinolone inhibitors of factor Xa
|
GB0007193D0
(en)
|
2000-03-25 |
2000-05-17 |
Univ Manchester |
Treatment of movrmrnt disorders
|
US6403588B1
(en)
|
2000-04-27 |
2002-06-11 |
Yamanouchi Pharmaceutical Co., Ltd. |
Imidazopyridine derivatives
|
CA2407573C
(en)
|
2000-04-27 |
2011-09-13 |
Yamanouchi Pharmaceutical Co. Ltd. |
Imidazopyridine derivatives
|
TWI282786B
(en)
|
2000-04-28 |
2007-06-21 |
Nihon Nohyaku Co Ltd |
A process for preparing 2-halogenobenzoic acids
|
WO2001083431A1
(fr)
|
2000-04-28 |
2001-11-08 |
Shionogi & Co., Ltd. |
Inhibiteurs de mmp-12
|
WO2001085716A1
(en)
|
2000-05-11 |
2001-11-15 |
Kyowa Hakko Kogyo Co., Ltd |
2-piperidone compounds for the treatment of cancer
|
MXPA02011053A
(es)
|
2000-05-11 |
2004-08-19 |
Kenneth Curry |
Compuestos novedosos de carboxi amino espiro (2,4)heptano y derivados de los mismos.
|
US20020009713A1
(en)
|
2000-05-11 |
2002-01-24 |
Miller Freda D. |
Methods for identifying modulators of neuronal growth
|
US7081481B2
(en)
|
2000-05-31 |
2006-07-25 |
Eli Lilly And Company |
Excitatory amino acid receptor modulators
|
WO2001096308A1
(fr)
|
2000-06-12 |
2001-12-20 |
Eisai Co., Ltd. |
Composes 1,2-dihydropyridine, leur procede de preparation et leur utilisation
|
AU2001276610A1
(en)
|
2000-06-27 |
2002-01-08 |
Centre National De La Recherche Scientifique-Cnrs |
Mammal 2p domain mechano-sensitive k+ channel, cloning and applications thereof
|
JP2002003401A
(ja)
|
2000-06-27 |
2002-01-09 |
Japan Science & Technology Corp |
脳由来神経栄養因子誘導剤
|
JP2002012533A
(ja)
|
2000-06-27 |
2002-01-15 |
Kao Corp |
染毛剤組成物
|
EP1295865A4
(en)
|
2000-06-28 |
2005-06-01 |
Taisho Pharmaceutical Co Ltd |
NEW DICARBOXYLENE DERIVATIVES
|
DE10031390A1
(de)
|
2000-07-03 |
2002-01-17 |
Knoll Ag |
Pyrimidinderivate und ihre Verwendung zur Prophylaxe und Therapie der zerebralen Ischämie
|
US20020041880A1
(en)
|
2000-07-05 |
2002-04-11 |
Defeo-Jones Deborah |
Method of treating cancer
|
US6861530B2
(en)
|
2000-07-07 |
2005-03-01 |
Kyowa Hakko Kogyo Co., Ltd. |
Piperidine derivatives
|
JP2002040252A
(ja)
|
2000-07-27 |
2002-02-06 |
Shiseido Co Ltd |
コレステリック液晶層を含む光学シート、それを用いた情報記録体、情報記録方法並びに情報判別方法
|
DE10038019A1
(de)
|
2000-08-04 |
2002-02-14 |
Bayer Ag |
Substituierte Triazolopyrid(az)ine
|
WO2002014282A1
(fr)
|
2000-08-11 |
2002-02-21 |
Eisai Co., Ltd. |
Composes 2-aminopyridine et leur utilisation comme medicaments
|
MXPA03002032A
(es)
|
2000-09-11 |
2003-07-24 |
Chiron Corp |
Derivados de quinolinona.
|
US6599940B2
(en)
|
2000-09-13 |
2003-07-29 |
Georgetown University |
Synthesis of 2-hydroxymethylglutamic acid and congeners thereof
|
JP2002105085A
(ja)
|
2000-09-28 |
2002-04-10 |
Yamanouchi Pharmaceut Co Ltd |
新規イミダゾチアゾール誘導体
|
WO2002028837A1
(en)
|
2000-10-02 |
2002-04-11 |
Janssen Pharmaceutica N.V. |
Metabotropic glutamate receptor antagonists
|
DE10058663A1
(de)
|
2000-11-25 |
2002-05-29 |
Merck Patent Gmbh |
Verwendung von Thienopyrimidinen
|
JPWO2002051849A1
(ja)
|
2000-12-26 |
2004-04-22 |
第一製薬株式会社 |
Cdk4活性阻害剤
|
JP2002308882A
(ja)
|
2001-02-08 |
2002-10-23 |
Yamanouchi Pharmaceut Co Ltd |
チエノピリミジン誘導体
|
AU2002258400A1
(en)
|
2001-02-16 |
2002-08-28 |
Tularik Inc. |
Methods of using pyrimidine-based antiviral agents
|
ES2360205T3
(es)
|
2001-03-02 |
2011-06-01 |
Agennix Ag |
Sistema de ensayo de tres híbridos.
|
AU2002308354A1
(en)
|
2001-03-08 |
2002-09-24 |
Ilfa Industrieelektronik Und Leiterplattenfertigung Aller Art Gmbh |
Multilayer printed circuit board
|
US6596731B2
(en)
|
2001-03-27 |
2003-07-22 |
Hoffmann-La Roche Inc. |
Substituted imidazo[1,2-A] pyridine derivatives
|
WO2002079498A1
(en)
|
2001-04-02 |
2002-10-10 |
Merck & Co., Inc. |
In vivo methods of determining activity of receptor-type kinase inhibitors
|
WO2002083665A1
(en)
|
2001-04-12 |
2002-10-24 |
F. Hoffmann-La Roche Ag |
DIHYDRO-BENZO[b][1,4]DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS I
|
KR100566171B1
(ko)
|
2001-04-12 |
2006-03-29 |
에프. 호프만-라 로슈 아게 |
mGluR2 길항제 Ⅱ인디하이드로-벤조[b][1,4]디아제핀-2-온 유도체
|
SE0101579D0
(sv)
|
2001-05-04 |
2001-05-04 |
Astrazeneca Ab |
New compounds
|
CA2446980A1
(en)
|
2001-05-14 |
2002-11-21 |
Argyrios G. Arvanitis |
Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
|
WO2002094264A1
(en)
|
2001-05-23 |
2002-11-28 |
Tularik Inc. |
Ccr4 antagonists
|
CA2448306A1
(en)
|
2001-05-30 |
2002-12-05 |
Alteon Inc. |
Method for treating fibrotic diseases or other indications
|
EP1414464A4
(en)
|
2001-05-30 |
2005-06-22 |
Alteon Inc |
METHOD OF TREATING GLAUCOMA
|
ATE338035T1
(de)
|
2001-06-05 |
2006-09-15 |
Boehringer Ingelheim Pharma |
1,4-disubstituierte benzokondensierte cycloalkyl harnstoffverbindungen
|
CA2451057A1
(en)
|
2001-06-14 |
2002-12-27 |
Banyu Pharmaceutical Co., Ltd. |
Novel isoxazolopyridone derivatives and use thereof
|
US7087614B2
(en)
|
2001-06-19 |
2006-08-08 |
Bristol-Myers Squibb Co. |
Pyrimidine inhibitors of phosphodiesterase (PDE) 7
|
JP2003012653A
(ja)
|
2001-06-28 |
2003-01-15 |
Yamanouchi Pharmaceut Co Ltd |
キナゾリン誘導体
|
EP1411941A2
(en)
|
2001-08-02 |
2004-04-28 |
Neurocrine Biosciences, Inc. |
Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists
|
US7427623B2
(en)
|
2001-09-11 |
2008-09-23 |
Smithkline Beecham Corporation |
4-Amino-2,3-disubstituted thieno[2,3-d]pyrimidines and pharmacetical compositions thereof
|
JP4459619B2
(ja)
|
2001-10-02 |
2010-04-28 |
グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー |
化合物
|
TWI330183B
(pt)
|
2001-10-22 |
2010-09-11 |
Eisai R&D Man Co Ltd |
|
TW200406466A
(en)
|
2001-11-13 |
2004-05-01 |
Ciba Sc Holding Ag |
Compositions comprising at least one oxonol dye and at least one metal complex
|
US6921762B2
(en)
|
2001-11-16 |
2005-07-26 |
Amgen Inc. |
Substituted indolizine-like compounds and methods of use
|
GB0129260D0
(en)
|
2001-12-06 |
2002-01-23 |
Eisai London Res Lab Ltd |
Pharmaceutical compositions and their uses
|
KR20040068240A
(ko)
|
2001-12-14 |
2004-07-30 |
노보 노르디스크 에이/에스 |
호르몬 민감성 리파아제의 활성을 감소시키기 위한 화합물및 그들의 사용
|
EP1465869B1
(en)
|
2001-12-21 |
2013-05-15 |
Exelixis Patent Company LLC |
Modulators of lxr
|
AU2002359923B2
(en)
|
2001-12-27 |
2007-12-20 |
Taisho Pharmaceutical Co., Ltd. |
6-fluorobicyclo[3.1.0]hexane derivatives
|
DE10164139A1
(de)
|
2001-12-27 |
2003-07-10 |
Bayer Ag |
2-Heteroarylcarbonsäureamide
|
JP2005170790A
(ja)
|
2002-01-09 |
2005-06-30 |
Ajinomoto Co Inc |
N−アルキルスルフォニル置換アミド誘導体
|
US7282512B2
(en)
|
2002-01-17 |
2007-10-16 |
Smithkline Beecham Corporation |
Cycloalkyl ketoamides derivatives useful as cathepsin K inhibitors
|
US20050113283A1
(en)
|
2002-01-18 |
2005-05-26 |
David Solow-Cordero |
Methods of treating conditions associated with an EDG-4 receptor
|
JP2005519915A
(ja)
|
2002-01-18 |
2005-07-07 |
セレテック・リミテッド・ライアビリティ・カンパニー |
Edg受容体に関連する症状の処置方法
|
WO2003064428A1
(en)
|
2002-01-29 |
2003-08-07 |
H. Lundbeck A/S |
Furano- and thienopyrimidines as neurokinase inhibitors
|
US6949542B2
(en)
|
2002-02-06 |
2005-09-27 |
Hoffman-La Roche Inc. |
Dihydro-benzo[b][1,4]diazepin-2-one derivatives
|
US20030220280A1
(en)
|
2002-02-07 |
2003-11-27 |
Bunge Mary Bartlett |
Schwann cell bridge implants and phosphodiesterase inhibitors to stimulate CNS nerve regeneration
|
US20040116489A1
(en)
|
2002-02-12 |
2004-06-17 |
Massey Steven Marc |
Synthetic excitatory amino acids
|
EP1484320A1
(en)
|
2002-02-13 |
2004-12-08 |
Takeda Chemical Industries, Ltd. |
Jnk inhibitor
|
CN100486576C
(zh)
|
2002-02-14 |
2009-05-13 |
法玛西雅公司 |
作为p38map激酶调节剂的取代吡啶酮类
|
CA2476681A1
(en)
*
|
2002-02-19 |
2003-08-28 |
Bruce N. Rogers |
Fused bicyclic-n-bridged-heteroaromatic carboxamides for the treatment of disease
|
AU2003205558A1
(en)
|
2002-02-19 |
2003-09-09 |
H. Lundbeck A/S |
Thioibotenic acid and derivatives thereof
|
US6833380B2
(en)
|
2002-03-07 |
2004-12-21 |
Warner-Lambert Company, Llc |
Compounds that modulate PPAR activity and methods of preparation
|
CN1653047A
(zh)
|
2002-03-14 |
2005-08-10 |
拜耳医药保健股份公司 |
抗炎症药物单环芳酰吡啶酮
|
US7271266B2
(en)
|
2002-03-28 |
2007-09-18 |
Merck & Co., Inc. |
Substituted 2,3-diphenyl pyridines
|
AU2003226737B2
(en)
|
2002-03-29 |
2008-09-04 |
Janssen Pharmaceutica N.V. |
Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
|
JP2005528378A
(ja)
|
2002-04-03 |
2005-09-22 |
イーライ・リリー・アンド・カンパニー |
非定型抗精神病薬およびmGLU2/3受容体アゴニストを組み合わせた精神病治療
|
US6864261B2
(en)
|
2002-05-02 |
2005-03-08 |
Euro-Celtique S.A. |
Therapeutic agents useful for treating pain
|
US7125888B2
(en)
|
2002-05-02 |
2006-10-24 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
WO2003099808A1
(en)
|
2002-05-21 |
2003-12-04 |
Amgen Inc. |
Substituted heterocyclic compounds and methods of use
|
EA011231B1
(ru)
|
2002-06-11 |
2009-02-27 |
Эли Лилли Энд Компани |
Пролекарство возбуждающей аминокислоты и его применение
|
KR101052433B1
(ko)
|
2002-06-13 |
2011-07-29 |
버텍스 파마슈티칼스 인코포레이티드 |
자이라제 및/또는 토포이소머라제 ⅳ 억제제로서의 2-우레이도-6-헤테로아릴-3h-벤조이미다졸-4-카복실산 유도체 및 이를 포함하는 세균 감염 치료용 약제학적 조성물
|
MY141867A
(en)
|
2002-06-20 |
2010-07-16 |
Vertex Pharma |
Substituted pyrimidines useful as protein kinase inhibitors
|
GB0214268D0
(en)
|
2002-06-20 |
2002-07-31 |
Celltech R&D Ltd |
Chemical compounds
|
WO2004004720A1
(en)
|
2002-07-03 |
2004-01-15 |
Astex Technology Limited |
3-`(hetero) arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors
|
US7262194B2
(en)
|
2002-07-26 |
2007-08-28 |
Euro-Celtique S.A. |
Therapeutic agents useful for treating pain
|
US20040138238A1
(en)
|
2002-08-08 |
2004-07-15 |
Dhanoa Dale S. |
Substituted aminopyrimidine compounds as neurokinin antagonists
|
GB0218630D0
(en)
|
2002-08-10 |
2002-09-18 |
Tanabe Seiyaku Co |
Novel compounds
|
GB0218800D0
(en)
|
2002-08-13 |
2002-09-18 |
Celltech R&D Ltd |
Chemical compounds
|
WO2004017950A2
(en)
|
2002-08-22 |
2004-03-04 |
Piramed Limited |
Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents
|
EP1556038A2
(en)
|
2002-08-26 |
2005-07-27 |
Merck & Co., Inc. |
Acetophenone potentiators of metabotropic glutamate receptors
|
EP1551369A4
(en)
|
2002-08-28 |
2007-05-09 |
Intermune Inc |
COMBINATION THERAPY FOR THE TREATMENT OF FIBROTIC DISEASES
|
MY139563A
(en)
|
2002-09-04 |
2009-10-30 |
Bristol Myers Squibb Co |
Heterocyclic aromatic compounds useful as growth hormone secretagogues
|
JP2006501265A
(ja)
|
2002-09-10 |
2006-01-12 |
ノバルティス アクチエンゲゼルシャフト |
嗜癖および鬱病を含むmgluレセプターに関連する疾患を処置するためのmgluレセプターアンタゴニスト
|
EP1546201A4
(en)
|
2002-09-11 |
2006-08-16 |
Merck & Co Inc |
NUCLEIC ACID SEQUENCES CODING TO MGLUR2 AND MGLUR3 FOR NEW POINT MUTATIONS
|
WO2004026875A1
(en)
|
2002-09-19 |
2004-04-01 |
Boehringer Ingelheim (Canada) Ltd. |
Non-nucleoside reverse transcriptase inhibitors
|
WO2004085437A1
(en)
|
2002-09-19 |
2004-10-07 |
Boehringer Ingelheim (Canada) Ltd. |
Non-nucleoside reverse transcriptase inhibitors
|
AR044743A1
(es)
|
2002-09-26 |
2005-10-05 |
Nihon Nohyaku Co Ltd |
Herbicida, metodo de emplearlo, derivados de tienopirimidina sustituida,compuestos intermediarios, y procedimientos que se utilizan para producirlos,
|
US7067658B2
(en)
|
2002-09-30 |
2006-06-27 |
Bristol-Myers Squibb Company |
Pyridino and pyrimidino pyrazinones
|
US7998163B2
(en)
|
2002-10-03 |
2011-08-16 |
Boston Scientific Scimed, Inc. |
Expandable retrieval device
|
EP1555324B1
(en)
|
2002-10-23 |
2009-12-02 |
Daiichi Pure Chemicals Co., Ltd. |
Defructosylation method
|
US20040138204A1
(en)
|
2002-10-30 |
2004-07-15 |
Harrington James Frederick |
Compositions and methods for pain reduction
|
KR20050065670A
(ko)
|
2002-11-01 |
2005-06-29 |
아보트 러보러터리즈 |
항감염제
|
US7902203B2
(en)
|
2002-11-01 |
2011-03-08 |
Abbott Laboratories, Inc. |
Anti-infective agents
|
US6930117B2
(en)
|
2002-11-09 |
2005-08-16 |
The Procter & Gamble Company |
N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
|
ATE527250T1
(de)
|
2002-11-21 |
2011-10-15 |
Novartis Ag |
2,4,6-trisubstituierten pyrimidinen als phosphotidylinositol (pi) 3-kinase inhibitoren und deren verwendung zur behandlung von krebs
|
WO2004054979A1
(ja)
|
2002-12-18 |
2004-07-01 |
Takeda Pharmaceutical Company Limited |
Jnk阻害剤
|
DE60330187D1
(de)
|
2002-12-30 |
2009-12-31 |
Celgene Corp |
Fluoralkoxy-substituierte 1, 3-dihydro-isoindolyl-verbindungen und ihre pharmazeutischen verwendungen
|
RS20050532A
(en)
|
2003-01-14 |
2007-12-31 |
Arena Pharmaceuticals Inc., |
1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
|
ITMI20030151A1
(it)
|
2003-01-30 |
2004-07-31 |
Recordati Ind Chimica E Farma Ceutica S P A |
Uso di antagonisti selettivi del recettore mglu5 per il trattamento di disfunzioni neuromuscolari del tratto urinario inferiore.
|
CA2514267C
(en)
|
2003-02-04 |
2011-05-17 |
F. Hoffmann-La Roche Ag |
Malonamide derivatives as gamma-secretase inhibitors
|
DE10306250A1
(de)
|
2003-02-14 |
2004-09-09 |
Aventis Pharma Deutschland Gmbh |
Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
PL378295A1
(pl)
|
2003-02-24 |
2006-03-20 |
Arena Pharmaceuticals, Inc. |
Podstawione pochodne arylowe i heteroarylowe jako modulatory metabolizmu glukozy oraz profilaktyka i leczenie zaburzeń tego metabolizmu
|
AU2004216813B2
(en)
|
2003-03-03 |
2008-09-11 |
F. Hoffmann-La Roche Ag |
2,5- and 2,6-substituted tetrahydroisoquinolines for use as 5-HT6 modulators
|
ITFI20030058A1
(it)
|
2003-03-06 |
2004-09-07 |
Univ Firenze |
Formulazioni farmaceutiche contenenti tiazolidinedioni
|
DE10311065A1
(de)
|
2003-03-13 |
2004-09-23 |
Abbott Gmbh & Co. Kg |
Pyrimidin-2-on-Verbindungen und ihre therapeutische Verwendung
|
WO2004092123A2
(en)
|
2003-04-10 |
2004-10-28 |
Microbia, Inc. |
Inhibitors of fungal invasion
|
ES2300798T3
(es)
|
2003-04-15 |
2008-06-16 |
Astrazeneca Ab |
Benzosulfonamidas sustituidas como potenciadores de los receptores de glutamato.
|
JP2004339080A
(ja)
|
2003-05-13 |
2004-12-02 |
Tokyo Institute Of Technology |
ピラゾ−ル誘導体を含有する高血圧治療剤
|
CA2525547C
(en)
|
2003-05-14 |
2012-07-03 |
Torreypines Therapeutics, Inc. |
Compounds and uses thereof in modulating amyloid beta
|
US20070053831A1
(en)
|
2003-05-20 |
2007-03-08 |
Barrio Jorge R |
Methods for binding agents to b-amyloid plaques
|
GB0315950D0
(en)
|
2003-06-11 |
2003-08-13 |
Xention Discovery Ltd |
Compounds
|
EP1680125A1
(en)
|
2003-07-02 |
2006-07-19 |
Warner-Lambert Company LLC |
Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor
|
CA2532203A1
(en)
|
2003-07-14 |
2005-01-27 |
Decode Genetics Ehf. |
Method of diagnosis and treatment for asthma based on haplotype association
|
GB0320300D0
(en)
|
2003-08-29 |
2003-10-01 |
Cancer Rec Tech Ltd |
Pyrimidothiophene compounds
|
CA2537135C
(en)
|
2003-08-29 |
2013-10-08 |
Vernalis (Cambridge) Limited |
Pyrimidothiophene compounds
|
GB0322016D0
(en)
|
2003-09-19 |
2003-10-22 |
Merck Sharp & Dohme |
New compounds
|
BRPI0507498A
(pt)
|
2004-02-18 |
2007-07-10 |
Astrazeneca Ab |
composto, composição farmacêutica, uso do composto, e, métodos para tratar distúrbios mediados por mglur 5 e para inibir ativação de receptores de mglur 5
|
DE102004009039A1
(de)
|
2004-02-23 |
2005-09-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8-[3-Amino-piperidin-1-yl]-xanthine, deren Herstellung und Verwendung als Arzneimittel
|
US7306631B2
(en)
|
2004-03-30 |
2007-12-11 |
The Procter & Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
AU2005233437A1
(en)
|
2004-04-12 |
2005-10-27 |
Sankyo Company, Limited |
Thienopyridine derivatives
|
US7459562B2
(en)
|
2004-04-23 |
2008-12-02 |
Bristol-Myers Squibb Company |
Monocyclic heterocycles as kinase inhibitors
|
GB0413605D0
(en)
|
2004-06-17 |
2004-07-21 |
Addex Pharmaceuticals Sa |
Novel compounds
|
US8063004B2
(en)
|
2004-07-22 |
2011-11-22 |
Malcera, L.L.C. |
Chemical composition of matter for the liquefaction and dissolution of asphaltene and paraffin sludges into petroleum crude oils and refined products at ambient temperatures and method of use
|
WO2006015158A1
(en)
|
2004-07-30 |
2006-02-09 |
Merck & Co., Inc. |
Indanone potentiators of metabotropic glutamate receptors
|
CA2574956A1
(en)
|
2004-07-30 |
2006-02-09 |
Merck & Co., Inc. |
Heterocyclic acetophenone potentiators of metabotropic glutamate receptors
|
DE502005003491D1
(de)
|
2004-08-02 |
2008-05-08 |
Sanol Arznei Schwarz Gmbh |
Carboxamide des indolizins und seiner aza- und diazaderivate
|
US20080097210A1
(en)
|
2004-08-11 |
2008-04-24 |
Koninklijke Philips Electronics N.V. |
Ultrasonic Diagnosis of Ischemic Cardiodisease
|
TW200613272A
(en)
|
2004-08-13 |
2006-05-01 |
Astrazeneca Ab |
Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
|
MX2007001612A
(es)
|
2004-08-18 |
2007-04-10 |
Upjohn Co |
Compuestos novedosos de triazolopiridina para el tratamiento de la inflamacion.
|
DE102004044884A1
(de)
|
2004-09-14 |
2006-05-24 |
Grünenthal GmbH |
Substituierte bizyklische Imidazo-3-yl-amin-Verbindungen
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
GB0420719D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
JP2008517920A
(ja)
|
2004-10-25 |
2008-05-29 |
メルク エンド カムパニー インコーポレーテッド |
代謝調節型グルタミン酸受容体の複素環式インダノン増強因子
|
WO2006057870A1
(en)
|
2004-11-22 |
2006-06-01 |
Eli Lilly And Company |
Potentiators of glutamate receptors
|
US7434262B2
(en)
|
2004-12-08 |
2008-10-07 |
At&T Intellectual Property I, L.P. |
Methods and systems that selectively resurrect blocked communications between devices
|
DE102004061288A1
(de)
|
2004-12-14 |
2006-06-29 |
Schering Ag |
3-Amino-Pyrazolo[3,4b]pyridine als Inhibitoren von Proteintyrosinkinasen, deren Herstellung und Verwendung als Arzneimittel
|
KR20070106690A
(ko)
|
2004-12-27 |
2007-11-05 |
아스트라제네카 아베 |
피라졸론 화합물 및 대사성 글루타메이트 수용체길항제로서 그들의 용도
|
US7456289B2
(en)
|
2004-12-31 |
2008-11-25 |
National Health Research Institutes |
Anti-tumor compounds
|
CA2598531A1
(en)
|
2005-02-24 |
2006-08-31 |
Merck & Co., Inc. |
Benzazole potentiators of metabotropic glutamate receptors
|
CA2602444C
(en)
|
2005-03-23 |
2013-03-19 |
F.Hoffmann-La Roche Ag |
Acetylenyl-pyrazolo-pyrimidine derivatives as mglur2 antagonists
|
RU2007141401A
(ru)
|
2005-04-08 |
2009-05-20 |
ЭЙСАЙ Ар энд Ди МЕНЕДЖМЕНТ КО., ЛТД. (JP) |
Терапевтический агент для лечения дискинезии
|
US7579360B2
(en)
|
2005-06-09 |
2009-08-25 |
Bristol-Myers Squibb Company |
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
US7572807B2
(en)
|
2005-06-09 |
2009-08-11 |
Bristol-Myers Squibb Company |
Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors
|
JPWO2006137350A1
(ja)
|
2005-06-22 |
2009-01-15 |
キッセイ薬品工業株式会社 |
新規なフロピリジン誘導体、それを含有する医薬組成物およびそれらの用途
|
BRPI0614168A2
(pt)
|
2005-08-05 |
2017-07-25 |
Astrazeneca Ab |
Composto ou um sal, hidrato, solvato, isoforma, tautômero, isômero óptico farmaceuticamente aceitável ou uma combinação dos mesmos, composição farmacêutica, método para o tratamento ou prevenção de distúrbios neurológicos e psquiátricos, uso de um composto, e, processo para a preparação de um composto
|
JP2009509921A
(ja)
|
2005-08-12 |
2009-03-12 |
アストラゼネカ アクチボラグ |
置換イソインドロン類及び代謝調節型グルタミン酸受容体増強剤としてのその使用
|
WO2007027669A1
(en)
|
2005-08-29 |
2007-03-08 |
Cps Biofuels, Inc. |
Improved biodiesel fuel, additives, and lubbricants
|
EP1764099A3
(en)
|
2005-09-17 |
2007-05-09 |
Speedel Experimenta AG |
Diaminoalcohol derivatives for the treatment of Alzheimer, malaria, HIV
|
PT1948654E
(pt)
|
2005-09-17 |
2009-09-28 |
Novartis Ag |
Derivados da 5-amino-4-hidroxi-7-(imidazo[1,2-a] piridin-6-ilmetil)-8-metil-nonamida e compostos relacionados como inibidores da renina para o tratamento da hipertensão
|
US8492428B2
(en)
|
2005-09-20 |
2013-07-23 |
Mayo Foundation For Medical Education And Research |
Small-molecule botulinum toxin inhibitors
|
BRPI0616571A2
(pt)
|
2005-09-27 |
2011-06-21 |
Hoffmann La Roche |
oxadiazolil pirazol-piridiminas como antagonistas de mglur2, processo para sua preparação, composição farmacêutica que os contém e uso dos mesmo
|
RU2428421C2
(ru)
|
2005-11-15 |
2011-09-10 |
Эррей Байофарма Инк. |
Производные n4-фенилхиназолин-4-амина и родственные соединения в качестве ингибиторов рецепторной тирозинкиназы типа erbb для лечения гиперпролиферативных заболеваний
|
AR057218A1
(es)
|
2005-12-15 |
2007-11-21 |
Astra Ab |
Compuestos de oxazolidinona y su uso como pontenciadores del receptor metabotropico de glutamato
|
TW200804281A
(en)
|
2006-02-16 |
2008-01-16 |
Astrazeneca Ab |
New metabotropic glutamate receptor-potentiating isoindolones
|
US20090203732A1
(en)
|
2006-03-02 |
2009-08-13 |
Dashyant Dhanak |
Thiazolones for Use as P13 Kinase Inhibitors
|
AR059898A1
(es)
|
2006-03-15 |
2008-05-07 |
Janssen Pharmaceutica Nv |
Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
|
GB0606774D0
(en)
|
2006-04-03 |
2006-05-10 |
Novartis Ag |
Organic compounds
|
GB0608263D0
(en)
|
2006-04-26 |
2006-06-07 |
Glaxo Group Ltd |
Compounds
|
WO2007135529A2
(en)
|
2006-05-23 |
2007-11-29 |
Pfizer Products Inc. |
Azabenzimidazolyl compounds as mglur2 potentiators
|
WO2007135527A2
(en)
|
2006-05-23 |
2007-11-29 |
Pfizer Products Inc. |
Benzimidazolyl compounds
|
ATE556061T1
(de)
|
2006-06-19 |
2012-05-15 |
Toray Industries |
Therapeutisches oder prophylaktisches mittel gegen multiple sklerose
|
WO2008006540A1
(en)
*
|
2006-07-12 |
2008-01-17 |
Syngenta Participations Ag |
Triazolopyridine derivatives as herbicides
|
US8217177B2
(en)
|
2006-07-14 |
2012-07-10 |
Amgen Inc. |
Fused heterocyclic derivatives and methods of use
|
US8198448B2
(en)
|
2006-07-14 |
2012-06-12 |
Amgen Inc. |
Fused heterocyclic derivatives and methods of use
|
PE20080403A1
(es)
|
2006-07-14 |
2008-04-25 |
Amgen Inc |
Derivados heterociclicos fusionados y metodos de uso
|
WO2008012623A1
(en)
|
2006-07-25 |
2008-01-31 |
Pfizer Products Inc. |
Benzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor
|
WO2008012622A2
(en)
|
2006-07-25 |
2008-01-31 |
Pfizer Products Inc. |
Azabenzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor
|
CN101511802A
(zh)
|
2006-09-13 |
2009-08-19 |
阿斯利康(瑞典)有限公司 |
螺唑烷酮化合物及其作为代谢型谷氨酸受体增效剂的用途
|
CA2665195C
(en)
|
2006-10-11 |
2011-08-09 |
Amgen Inc. |
Imidazo- and triazolo-pyridine compounds and methods of use thereof
|
EP2089389A2
(en)
|
2006-11-01 |
2009-08-19 |
Bristol-Myers Squibb Company |
Heterocyclic compounds as modulators of glucocorticoid receptor, ap-1, and/or nf-kappa-b activity
|
TW200831085A
(en)
|
2006-12-13 |
2008-08-01 |
Merck & Co Inc |
Non-nucleoside reverse transcriptase inhibitors
|
US8895745B2
(en)
|
2006-12-22 |
2014-11-25 |
Astex Therapeutics Limited |
Bicyclic heterocyclic compounds as FGFR inhibitors
|
CA2672213C
(en)
|
2006-12-22 |
2016-02-16 |
Astex Therapeutics Limited |
Bicyclic amine derivatives as protein tyrosine kinase inhibitors
|
JP2010518104A
(ja)
|
2007-02-09 |
2010-05-27 |
アストラゼネカ・アクチエボラーグ |
アザ−イソインドロンおよび代謝型グルタミン酸レセプター増強剤−613としてのそれらの使用
|
ES2320955B1
(es)
|
2007-03-02 |
2010-03-16 |
Laboratorios Almirall S.A. |
Nuevos derivados de 3-((1,2,4)triazolo(4,3-a)piridin-7-il)benzamida.
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
TW200900391A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-phenyl-piperidin-1-yl)-pyridin-2-one derivatives
|
MX2009009520A
(es)
|
2007-03-07 |
2009-11-18 |
Janssen Pharmaceutica Nv |
Fenoxiaminotiazolonas sustituidas como moduladores del receptor alfa relacionados con estrogenos.
|
PL2132188T3
(pl)
|
2007-03-07 |
2012-05-31 |
Janssen Pharmaceutica Nv |
N-alkilowane tiazolodienodiony podstawione grupą fenoksylową jako modulatory receptora spokrewnionego z receptorem estrogenowym alfa
|
GB0704407D0
(en)
|
2007-03-07 |
2007-04-18 |
Glaxo Group Ltd |
Compounds
|
CN101679322A
(zh)
|
2007-03-07 |
2010-03-24 |
詹森药业有限公司 |
用作***相关性受体-α调节剂的取代苯氧基噻唑烷二酮类化合物
|
CA2680262C
(en)
|
2007-03-09 |
2012-11-13 |
Sanofi-Aventis |
Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
|
WO2008124085A2
(en)
|
2007-04-03 |
2008-10-16 |
Exelixis, Inc. |
Methods of using combinations of mek and jak-2 inhibitors
|
WO2008130853A1
(en)
|
2007-04-17 |
2008-10-30 |
Astrazeneca Ab |
Hydrazides and their use as metabotropic glutamate receptor potentiators - 681
|
TWI443090B
(zh)
|
2007-05-25 |
2014-07-01 |
Abbvie Deutschland |
作為代謝性麩胺酸受體2(mglu2 受體)之正向調節劑之雜環化合物
|
TWI417100B
(zh)
|
2007-06-07 |
2013-12-01 |
Astrazeneca Ab |
二唑衍生物及其作為代謝型麩胺酸受體增效劑-842之用途
|
TW200911255A
(en)
|
2007-06-07 |
2009-03-16 |
Astrazeneca Ab |
Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators-841
|
WO2009004430A1
(en)
|
2007-06-29 |
2009-01-08 |
Pfizer Inc. |
N-benzyl oxazolidinones and related heterocycleic compounds as potentiators of glutamate receptors
|
MY152078A
(en)
|
2007-09-14 |
2014-08-15 |
Ortho Mcneil Janssen Pharm |
1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h,1'h-[1,4']bipyridinyl-2'-ones
|
CN101848893B
(zh)
|
2007-09-14 |
2012-06-06 |
奥梅-杨森制药有限公司 |
1,3-二取代的4-(芳基-x-苯基)-1h-吡啶-2-酮
|
CA2698929C
(en)
|
2007-09-14 |
2016-01-19 |
Addex Pharma S.A. |
1,3-disubstituted-4-phenyl-1h-pyridin-2-ones
|
US8119658B2
(en)
|
2007-10-01 |
2012-02-21 |
Bristol-Myers Squibb Company |
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
MX2010005110A
(es)
|
2007-11-14 |
2010-09-09 |
Ortho Mcneil Janssen Pharm |
Derivados de imidazo[1,2-a]piridina y su uso como moduladores alostericos positivos de los receptores de glutamato metabotropico 2.
|
US20100292241A1
(en)
|
2008-01-24 |
2010-11-18 |
Merck Sharp & Dohme Corp. |
3,5-substituted-1,3-oxazolidin-2-one derivatives
|
JP5309162B2
(ja)
|
2008-03-06 |
2013-10-09 |
サノフイ |
置換されたジヒドロ、トリヒドロ及びテトラヒドロシクロアルキルオキサゾロピリミジノン、その製造及び使用
|
DE102008001056A1
(de)
|
2008-04-08 |
2009-10-15 |
Robert Bosch Gmbh |
Umlenkeinrichtung für einen Strahl einer elektromagnetischen Welle
|
US20110065669A1
(en)
|
2008-05-15 |
2011-03-17 |
Merck Sharp & Dohme Corp. |
Oxazolobenzimidazole derivatives
|
EP2291078A4
(en)
|
2008-05-15 |
2011-08-24 |
Merck Sharp & Dohme |
OXAZOLBENZIMIDAZOLDERIVATE
|
US7790760B2
(en)
|
2008-06-06 |
2010-09-07 |
Astrazeneca Ab |
Metabotropic glutamate receptor isoxazole ligands and their use as potentiators 286
|
TW201006801A
(en)
|
2008-07-18 |
2010-02-16 |
Lilly Co Eli |
Imidazole carboxamides
|
JP5572625B2
(ja)
*
|
2008-07-25 |
2014-08-13 |
ハー・ルンドベック・アクチエゼルスカベット |
アダマンチルジアミド誘導体およびそれらの使用
|
UY32049A
(es)
|
2008-08-14 |
2010-03-26 |
Takeda Pharmaceutical |
Inhibidores de cmet
|
US8557809B2
(en)
|
2008-08-19 |
2013-10-15 |
Array Biopharma Inc. |
Triazolopyridine compounds as PIM kinase inhibitors
|
TWI496779B
(zh)
|
2008-08-19 |
2015-08-21 |
Array Biopharma Inc |
作為pim激酶抑制劑之***吡啶化合物
|
JP5547194B2
(ja)
|
2008-09-02 |
2014-07-09 |
ジャンセン ファーマシューティカルズ, インコーポレイテッド. |
代謝型グルタミン酸受容体の調節因子としての3−アザビシクロ[3.1.0]ヘキシル誘導体
|
EP2346505B1
(en)
|
2008-10-16 |
2014-04-23 |
Janssen Pharmaceuticals, Inc. |
Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
|
CN102232074B
(zh)
|
2008-11-28 |
2014-12-03 |
奥梅-杨森制药有限公司 |
作为代谢性谷氨酸盐受体调节剂的吲哚和苯并噁嗪衍生物
|
AT507619B1
(de)
|
2008-12-05 |
2011-11-15 |
Oesterreichisches Forschungs Und Pruefzentrum Arsenal Ges M B H |
Verfahren zur approximation des zeitlichen verlaufs von verkehrsdaten
|
US8637505B2
(en)
|
2009-02-04 |
2014-01-28 |
Boehringer Ingelheim International Gmbh |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
US9238647B2
(en)
*
|
2009-03-23 |
2016-01-19 |
Merck Sharp & Dohme Corp. |
P2X3 receptor antagonists for treatment of pain
|
WO2010114726A1
(en)
|
2009-03-31 |
2010-10-07 |
Merck Sharp & Dohme Corp. |
Aminobenzotriazole derivatives
|
WO2010117926A1
(en)
|
2009-04-07 |
2010-10-14 |
Schering Corporation |
Substituted triazolopyridines and analogs thereof
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
AU2010246607B2
(en)
|
2009-05-12 |
2012-09-27 |
Addex Pharma S.A. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
|
MX2011011964A
(es)
|
2009-05-12 |
2012-02-23 |
Janssen Pharmaceuticals Inc |
Derivados de 1,2,3-triazolo[4,3-a]piridina y su uso para el tratamiento o prevencion de trastornos neurologicos y psiquiatricos.
|
WO2010141360A1
(en)
|
2009-06-05 |
2010-12-09 |
Merck Sharp & Dohme Corp. |
Biaryl benzotriazole derivatives
|
US8975286B2
(en)
|
2009-08-20 |
2015-03-10 |
Merck Sharp & Dohme Corp. |
Ether benzotriazole derivatives
|
CN102002040A
(zh)
|
2009-09-01 |
2011-04-06 |
上海药明康德新药开发有限公司 |
一种***并吡啶环化合物的合成方法
|
AR078173A1
(es)
|
2009-09-15 |
2011-10-19 |
Sanofi Aventis |
Bifeniloximetil dihidro oxazolopirimidinonas sustituidas, su preparacion y su uso
|
AR078172A1
(es)
|
2009-09-15 |
2011-10-19 |
Sanofi Aventis |
Fenoximetil dihidro oxazolopirimidinonas sustituidas y uso de las mismas como moduladores de receptores metabotropicos de mglur
|
AR078171A1
(es)
|
2009-09-15 |
2011-10-19 |
Sanofi Aventis |
Dihidrobenzocicloalquiloximetil-oxazolopirimidinonas sustituidas, preparacion y uso de las mismas
|
WO2011034741A1
(en)
|
2009-09-15 |
2011-03-24 |
Merck Sharp & Dohme Corp. |
Imidazopyridin-2-one derivatives
|
JP5204071B2
(ja)
|
2009-09-25 |
2013-06-05 |
パナソニック株式会社 |
電気かみそり
|
EP2496569A2
(en)
|
2009-11-02 |
2012-09-12 |
MSD Oss B.V. |
Heterocyclic derivatives
|
EP2542083B1
(en)
|
2010-03-04 |
2015-05-06 |
Merck Sharp & Dohme Corp. |
Positive allosteric modulators of mglur2
|
WO2011116356A2
(en)
|
2010-03-19 |
2011-09-22 |
Sanford-Burnham Medical Research Institute |
Positive allosteric modulators of group ii mglurs
|
US8314120B2
(en)
|
2010-03-30 |
2012-11-20 |
Abbott Gmbh & Co. Kg |
Small molecule potentiators of metabotropic glutamate receptors
|
US8664214B2
(en)
|
2010-03-30 |
2014-03-04 |
AbbVie Deutschland GmbH & Co. KG |
Small molecule potentiators of metabotropic glutamate receptors I
|
US20130035332A1
(en)
|
2010-04-29 |
2013-02-07 |
Layton Mark E |
Substituted 1,3-Benzothiazol-2(3H)-Ones and [1,3]Thiazolo[5,4-B]Pyridin-2(IH)-Ones as Positive Allosteric Modulators of MGLUR2
|
KR20130094179A
(ko)
|
2010-04-30 |
2013-08-23 |
아스트라제네카 아베 |
대사형 글루탐산 수용체 양성 알로스테릭 조정자의 다형체
|
US8765784B2
(en)
|
2010-06-09 |
2014-07-01 |
Merck Sharp & Dohme Corp. |
Positive allosteric modulators of MGLUR2
|
CN101893589B
(zh)
|
2010-06-29 |
2012-10-17 |
中国人民解放军第三0二医院 |
一种无菌检查方法及其使用的全封闭集菌安瓿培养器
|
WO2012021382A1
(en)
|
2010-08-12 |
2012-02-16 |
Merck Sharp & Dohme Corp. |
Positive allosteric modulators of mglur2
|
US8785481B2
(en)
|
2010-09-29 |
2014-07-22 |
Merck Sharp & Dohme Corp. |
Ether benzotriazole derivatives
|
PL2649069T3
(pl)
|
2010-11-08 |
2016-01-29 |
Janssen Pharmaceuticals Inc |
Pochodne 1,2,4-triazolo[4,3-a]pirydyny i ich zastosowanie jako dodatnich allosterycznych modulatorów receptorów mGluR2
|
CA2815120A1
(en)
*
|
2010-11-08 |
2012-05-18 |
Jose Ignacio Andres-Gil |
Radiolabelled mglur2 pet ligands
|
CN103261195B
(zh)
|
2010-11-08 |
2015-09-02 |
杨森制药公司 |
1,2,4-***并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
|
WO2012062759A1
(en)
|
2010-11-08 |
2012-05-18 |
Janssen Pharmaceuticals, Inc. |
1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
|
EP2705024B1
(en)
|
2011-05-03 |
2015-12-16 |
Merck Sharp & Dohme Corp. |
Alkyne benzotriazole derivatives
|
EP2704573A4
(en)
|
2011-05-03 |
2014-10-15 |
Merck Sharp & Dohme |
AMINOMETHYL biaryl BENZOTRIAZOL DERIVATIVES
|
WO2012151140A1
(en)
|
2011-05-03 |
2012-11-08 |
Merck Sharp & Dohme Corp. |
Hydroxymethyl biaryl benzotriazole derivatives
|